Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$346 Mln
Revenue (TTM)
$215 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.2 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
1
Industry P/E
22.47
EV/EBITDA
-13
Div. Yield
0 %
Debt to Equity
0.5
Book Value
$--
EPS
$-2.2
Face value
--
Shares outstanding
50,137,200
CFO
$-33.76 Mln
EBITDA
$-176.27 Mln
Net Profit
$-510.89 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
CryoPort (CYRX)
| -13.4 | -4.7 | -4.3 | -36.5 | -35.3 | -22.9 | 0.3 |
|
BSE Sensex
| 3.7 | -1.6 | 9.6 | 5.9 | 14.3 | 19.1 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
CryoPort (CYRX)
| -49.5 | -10.7 | -70.7 | 34.8 | 166.6 | 49.2 | 28.2 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
CryoPort (CYRX)
|
6.7 | 346.5 | 214.8 | -109.8 | -42.8 | -26.9 | -- | 1.0 |
| 94.4 | 11,229.6 | 17,359.4 | 508.1 | 4.0 | 30.1 | 22.5 | 6.6 | |
| 43.4 | 4,993.3 | 12,230.0 | 75.0 | 2.1 | 2.4 | 69.3 | 1.7 | |
| 33.2 | 2,050.5 | 3,862.1 | 103.8 | 3.6 | 6.3 | 19.9 | 1.3 | |
| 43.1 | 7,078.3 | 7,412.0 | 150.9 | 3.4 | 2.2 | 48 | 1.0 | |
| 139.3 | 4,876.4 | 4,800.7 | 178.7 | 4.7 | 18.4 | 27.1 | 5.3 | |
| 15.6 | 2,704.6 | 5,070.0 | -306.0 | -0.9 | -38.5 | -- | 1.7 | |
| 148.3 | 6,203.2 | 12,703.0 | 502.0 | 8.1 | 16.6 | 13 | 2.1 | |
| 264.2 | 6,795.9 | 3,241.9 | 321.2 | 13.4 | 14 | 20.7 | 2.9 | |
| 24.3 | 4,330.9 | 5,373.3 | 124.6 | 3.4 | 4.2 | 33.9 | 1.4 |
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and... cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport ELITE Shippers; Cryoport Express Cryogenic HV3 Shipping System; Smartpak II Condition Monitoring System and Tec4Med; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; CRYOPDP, a temperature-controlled logistics solution; MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee. Address: 112 Westwood Place, Brentwood, TN, United States, 37027 Read more
Chairman, President & CEO
Mr. Jerrell W. Shelton
Chairman, President & CEO
Mr. Jerrell W. Shelton
Headquarters
Brentwood, TN
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of CryoPort Inc (CYRX) stood at $ 774 Mln as on 31-Mar-25
The share price of CryoPort Inc (CYRX) is $6.74 (NASDAQ) as of 13-Jun-2025 13:32 EDT. CryoPort Inc (CYRX) has given a return of -35.28% in the last 3 years.
CryoPort Inc (CYRX) has a market capitalisation of $ 346 Mln as on 12-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of CryoPort Inc (CYRX) is 0.96 times as on 12-Jun-2025, a 67% discount to its peers’ median range of 2.89 times.
Since, TTM earnings of CryoPort Inc (CYRX) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the CryoPort Inc (CYRX) and enter the required number of quantities and click on buy to purchase the shares of CryoPort Inc (CYRX).
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport ELITE Shippers; Cryoport Express Cryogenic HV3 Shipping System; Smartpak II Condition Monitoring System and Tec4Med; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; CRYOPDP, a temperature-controlled logistics solution; MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee. Address: 112 Westwood Place, Brentwood, TN, United States, 37027
The CEO & director of Mr. Jerrell W. Shelton. is CryoPort Inc (CYRX), and CFO & Sr. VP is Mr. Jerrell W. Shelton.
There is no promoter pledging in CryoPort Inc (CYRX).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,123
|
|
|
708
|
|
|
680
|
|
|
620
|
|
|
499
|
|
|
488
|
|
|
433
|
|
|
270
|
|
|
205
|
| CryoPort Inc. (CYRX) | Ratios |
|---|---|
|
Return on equity(%)
|
-26.88
|
|
Operating margin(%)
|
-42.84
|
|
Net Margin(%)
|
-51.13
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of CryoPort Inc (CYRX) was $0 Mln.
$-0.16
(
